FundedIQ
Biotechnology

Orano Med: Funding, Investors & Team (Sep 2026)

Orano Med is focused on creating advanced cancer treatments that target specific areas. The company specializes in high-quality chelating agents and offers a variety of products and services. Their strategy involves building a strong lineup of therapies and maintaining a steady supply of isotopes.

www.oranomed.com LinkedIn Plano, United States 101-250 employees
Biotechnology Clinical Trials Health Care Pharmaceutical
Total raised
$347M
Rounds
1
Latest
Undisclosed round
Oct 2025

Orano Med has raised $347M across 1 funding round on record, the most recent an undisclosed round of $347M announced in Oct 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Orano Med Company Profile and Key Stats

Total funding raised
$347M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$347M in Oct 2025
Employees
101-250
reported band
Headquarters
Plano, United States

Latest funding round on record: Oct 2025.

Orano Med Funding Rounds

Date
Round
Amount
Undisclosed round
$347M

Orano Med Founders and Leadership Team

Name
Role
Contact
Julien Dodet
Founder

No contact details are on record for this team yet.

Orano Med Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Orano Med's latest round of $347M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Orano Med in Biotechnology and Plano

Companies Similar to Orano Med

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Orano Med Funding FAQs

What does Orano Med do?

Orano Med is focused on creating advanced cancer treatments that target specific areas. The company specializes in high-quality chelating agents and offers a variety of products and services. Their strategy involves building a strong lineup of therapies and maintaining a steady supply of isotopes.

How much funding has Orano Med raised?

Orano Med has raised $347M across 1 round on record. The most recent is an undisclosed round of $347M announced in Oct 2025.

When did Orano Med last raise funding?

Orano Med's most recent funding round on record is an undisclosed round of $347M, announced in Oct 2025.

Who founded Orano Med?

FundedIQ lists Julien Dodet (Founder) at Orano Med.

Where is Orano Med headquartered?

Orano Med is based in Plano, Texas, United States.

How many employees does Orano Med have?

Orano Med is in the 101-250 employee band.

How does Orano Med's funding compare to other Biotechnology startups?

Orano Med's latest round of $347M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Orano Med Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Orano Med is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.